Join WeedWeek and BDSA Co-Founder Liz Stahura for a data-driven review of the trends that shaped the cannabis industry in 2025 and what they signal for 2026. Drawing on BDSA’s retail sales […]

There's no precedent for what to expect during this summer's hearings on moving REC to schedule three. Drug historian Emily Dufton, who's covering the hearings for WeedWeek, will discuss what she's looking for and what it could mean for the industry.

This month The DEA hosted historic hearings on whether to move REC to Schedule III. Drug historian Emily Dufton, who covered the process for WeedWeek will talk with editor Alex Halperin about what happened, the big surprises and what they mean for the cannabis industry's future.